PMID: 11903393Mar 21, 2002Paper

Protein kinase C and the development of diabetic vascular complications

Diabetic Medicine : a Journal of the British Diabetic Association
Kerrie J WayG L King

Abstract

Hyperglycemic control in diabetes is key to preventing the development and progression of vascular complications such as retinopathy, nephropathy and neuropathy. Increased activation of the diacylglycerol (DAG)-protein kinase C (PKC) signal transduction pathway has been identified in vascular tissues from diabetic animals, and in vascular cells exposed to elevated glucose. Vascular abnormalities associated with glucose-induced PKC activation leading to increased synthesis of DAG include altered vascular blood flow, extracellular matrix deposition, basement membrane thickening, increased permeability and neovascularization. Preferential activation of the PKCbeta isoform by elevated glucose is reported to occur in a variety of vascular tissues. This has lead to the development of LY333531, a PKCbeta isoform specific inhibitor, which has shown potential in animal models to be an orally effective and nontoxic therapy able to produce significant improvements in diabetic retinopathy, nephropathy, neuropathy and cardiac dysfunction. Additionally, the antioxidant vitamin E has been identified as an inhibitor of the DAG-PKC pathway, and shows promise in reducing vascular complications in animal models of diabetes. Given the overwhelming...Continue Reading

References

Oct 1, 1977·The Journal of Clinical Investigation·T J ReganB Haider
Mar 1, 1992·Cellular Signalling·R V FareseD R Cooper
Jan 1, 1991·The Journal of Clinical Investigation·B A WolfJ Turk
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S RoyM Lorenzi
Jun 1, 1990·The Journal of Clinical Investigation·J J LynchA B Malik
Oct 6, 1989·JAMA : the Journal of the American Medical Association·Y Nishizuka
May 1, 1989·The Journal of Clinical Investigation·P A Craven, F R DeRubertis
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T S LeeG L King
Mar 5, 1987·The New England Journal of Medicine·D A GreeneA A Sima
Mar 1, 1981·Kidney International·T H HostetterB M Brenner
Mar 1, 1995·Journal of Endocrinological Investigation·B J LooijJ P Schröder-van der Elst
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T YamamotoW A Border
Jan 1, 1995·Journal of Molecular and Cellular Cardiology·S F SteinbergV O Rybin

❮ Previous
Next ❯

Citations

May 8, 2002·Diabetes/metabolism Research and Reviews
Oct 25, 2008·Cardiovascular Drugs and Therapy·Nehal N MehtaMuredach P Reilly
May 24, 2003·Current Diabetes Reports·Mihaela C BlendeaJames R Sowers
Feb 20, 2004·Current Hypertension Reports·H Glenn Bohlen
Jun 1, 2013·Cell Biochemistry and Biophysics·Louis S Premkumar, Reddy M Pabbidi
Apr 6, 2005·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Ole Saetrum Opgaard, Ping H Wang
Jul 2, 2003·Experimental and Molecular Pathology·Alan W Stitt
Mar 8, 2003·Journal of Molecular and Cellular Cardiology·Steven Marx
Jan 1, 2003·Survey of Ophthalmology·Lloyd Paul Aiello
Sep 12, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·A AkulaJ P Gomedhikam
Dec 24, 2010·Journal of the American Chemical Society·Gary E KeckJonathan A Covel
Feb 9, 2010·Antioxidants & Redox Signaling·Carlotta GiorgiPaolo Pinton
Nov 19, 2011·Clinical and Experimental Pharmacology & Physiology·Yingxue SuBanghao Zhu
Dec 21, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·M FrossardM Müller
Jan 24, 2011·Journal of Diabetes Investigation·Soroku YagihashiKazuhiro Sugimoto
Oct 17, 2008·Physiological Reviews·Susan F Steinberg
May 1, 2010·Circulation Research·Pedro Geraldes, George L King
Sep 21, 2010·The Journal of Clinical Investigation·Ni-Huiping SonIra J Goldberg
Apr 29, 2005·Molecular Pain·Jeremy J Van BurenLouis S Premkumar
Mar 29, 2008·Journal of Ethnobiology and Ethnomedicine·Subramanyam RagupathyMuneer M Ul-Huda
Feb 25, 2010·Journal of Lipid Research·Takashi YamamotoHitoshi Shimano
Oct 22, 2004·Pediatric Research·Mattias Gäreskog, Parri Wentzel
Feb 23, 2013·Heart Failure Reviews·Rokhsana Mortuza, Subrata Chakrabarti
Nov 30, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Da-Wei ZouNa Zhang
Jan 28, 2014·Pharmacology & Therapeutics·Karina HuynhRebecca H Ritchie
Dec 13, 2006·Expert Opinion on Investigational Drugs·Stela S PaliiMaria B Grant
Apr 30, 2003·Expert Opinion on Biological Therapy·Sayon RoyAmy Chen
Jan 8, 2013·The Medical Clinics of North America·Deanna S KaniaBrian M Shepler
Apr 1, 2011·Kidney International·Gene-Yuan ChangKatalin Susztak
Oct 20, 2009·Progress in Biophysics and Molecular Biology·Eun A KoJin Han

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.